Published in J Lab Clin Med on November 01, 1976
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats. Urol Res (2003) 0.75
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
The living donor in kidney transplantation. Ann Intern Med (1987) 1.81
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin Hematol (1968) 1.58
Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46
Association of HLA-DRw4 with rheumatoid arthritis in black and white patients. Arthritis Rheum (1980) 1.42
Therapy of membranous nephropathy: what to do after the after (meta) analyses. J Am Soc Nephrol (1995) 1.39
Renoprotective therapy: how good can it get? Kidney Int (2000) 1.39
A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood (1976) 1.38
Defective candidacidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood. J Pediatr (1969) 1.37
The in vitro response to phytohemagglutinin of lyphoid cells from normal and neonatally thymectomized adult mice. Int Arch Allergy Appl Immunol (1969) 1.35
Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol (1982) 1.34
Progressive loss in vitro of cellular immunity with ageing in strains of mice susceptible to autoimmune disease. Clin Exp Immunol (1971) 1.28
CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27
Defective bactericidal activity of monocytes in fatal granulomatous disease. Blood (1969) 1.27
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18
Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17
Alternative complement pathway activity in sera from patients with sickle cell disease. Clin Exp Immunol (1976) 1.15
Nitroblue-tetrazolium test in children with fatal granulomatous disease and newborn infants. Lancet (1969) 1.14
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
In vitro immunization to KLH. II. Limiting dilution analysis of antigen-reactive cells in primary and secondary culture. J Immunol (1983) 1.08
In vitro response of human T cells to Pseudomonas aeruginosa. Infect Immun (1983) 1.07
The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int (1987) 1.07
Some hemodynamic determinants of immune complex trapping by the kidney. Kidney Int (1978) 1.05
Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol (1987) 1.04
Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03
Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease. J Immunogenet (1985) 1.02
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis (1999) 1.02
Modification of the in vitro response to phytohemagglutinin of mouse spleen cells by amyloidogenic agents. Proc Soc Exp Biol Med (1969) 1.01
Defective bactericidal activity of peripheral blood leukocytes in lipochrome histiocytosis. Am J Med (1970) 1.01
Diagnostic significance of hypocomplementemia. Kidney Int (1991) 0.97
Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes. J Immunol (1987) 0.97
Azathioprine decreases suppressor T cells in patients with multiple sclerosis. N Engl J Med (1982) 0.96
Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol (1990) 0.95
Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test. Transplantation (1982) 0.95
Response of peripheral blood lymphocytes from normal, hypogammaglobulinemic and chronic lymphocytic leukemic patients. J Immunol (1972) 0.95
Public epitopes and the antigenic structure of the HLA molecules. Crit Rev Immunol (1987) 0.94
Mitral valve prolapse: a consistent manifestation of type IV Ehlers-Danlos syndrome. The pathogenetic role of the abnormal production of type III collagen. Circulation (1981) 0.93
Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol (1999) 0.93
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol (2006) 0.92
Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis. J Exp Med (1982) 0.92
Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus (2011) 0.92
Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol (1977) 0.92
Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol (1997) 0.91
In vitro primary immunization of human peripheral blood lymphocytes to KLH: evidence for HLA-D region restriction. J Immunol (1979) 0.91
Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int (1991) 0.90
Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor. Clin Immunol Immunopathol (1984) 0.90
Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts. Cancer Res (1974) 0.89
Public antigenic determinant on a family of HLA-B molecules. J Clin Invest (1979) 0.88
HLA-DR specificities among black Americans with juvenile-onset diabetes. N Engl J Med (1979) 0.88
Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion (1996) 0.86
Immune complexes bind preferentially to specific subpopulations of human erythrocytes. Clin Immunol Immunopathol (1990) 0.85
Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus (2012) 0.85
Pretreatment of renal allograft recipients with immunosuppression and donor-specific blood. Transplantation (1984) 0.85
Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. J Lab Clin Med (1990) 0.84
The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions. Transplantation (1989) 0.83
Of mice and men: the relevance of the mouse to the study of human SLE. Immunol Res (2001) 0.83
Reversal of chronic end-stage renal failure due to myeloma kidney. Ann Intern Med (1979) 0.83
Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis. Recognition and treatment. JAMA (1982) 0.82
Renal subcapsular pressure--a new intrarenal pressure measurement. Am J Physiol (1971) 0.82
IgA deficiency, antigenic barriers, and autoimmunity. Cell Immunol (1970) 0.82
Histocompatibility antigens of human plasma. Localization to the HLD-3 lipoprotein fraction. Transplantation (1973) 0.81
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant (1997) 0.81
Renal artery pressure gradients in patients with angiographic evidence of atherosclerotic renal artery stenosis. Am J Kidney Dis (1994) 0.80
Effect of renal decapsulation on renal function. Am J Physiol (1975) 0.80
Stability of renal transplant function with alternate-day corticosteroid therapy. JAMA (1980) 0.79
Functional characteristics of TG and TnonG cells in a three party MLR. J Immunol (1981) 0.79
Blood transfusions and their influence on renal allograft survival. Prog Hematol (1986) 0.79
HLA antigens in black and white patients with juvenile arthritis: associations with rheumatoid factor, hidden rheumatoid factor, antinuclear antibodies, and immune complex levels. J Rheumatol (1984) 0.78
New approaches to donor crossmatching and successful transplantation of highly sensitized patients. Transplantation (1983) 0.78
Simple method for monitoring 24-hour urinary urea nitrogen excretion. J Lab Clin Med (1986) 0.78
Renal autotransplantation in the loin pain-hematuria syndrome: a cautionary note. Am J Kidney Dis (1992) 0.78
Cross-reactive HL-A antibodies. Separation of multiple HL-A antibody specificities by platelet adsorption and acid elution. Tissue Antigens (1973) 0.78
A comparison of taste acuity for salt in renal patients vs. normal subjects. J Am Diet Assoc (1987) 0.78
Renal expansion in saline loading. Am J Physiol (1974) 0.78
Adverse effect of exercise on immune complex-mediated glomerulonephritis. Nephron (1985) 0.78
In vitro primary immunization of human peripheral blood lymphocytes to KLH: evidence for HLA-D-region restriction. Transplant Proc (1979) 0.78
Prediction of crossmatch outcome in highly sensitized dialysis patients based on the identification of serum HLA antibodies. Transplantation (1986) 0.78
Splenic suppressor cells in hypogammaglobulinaemia. Br Med J (1977) 0.78
Nonenzymic glycation of human immunoglobulins does not impair their immunoreactivity. Clin Chem (1989) 0.78
A public antigenic determinant in the HLA-B5 cross-reacting group--a basis for cross-reactivity and a possible link with Behcet's disease. Hum Immunol (1980) 0.77
Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes. Hum Immunol (1990) 0.77
HLA public determinants are target antigens of cell-mediated cytotoxicity. J Exp Med (1980) 0.77
Primary hypothyroidism in chronic renal failure. Clin Nephrol (1986) 0.77
Platelet inhibitors in human renal homotransplantation: randomized comparison of aspirin versus dipyridamole. Transplant Proc (1980) 0.77
Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice. J Natl Cancer Inst (1975) 0.77
Histocompatibility leukocyte antigen and erythrocyte MNSs specificities in patients with meningitis or epiglottitis due to Haemophilus influenzae type b. J Infect Dis (1984) 0.77
Plasmapheresis in the treatment of renal allograft rejection. Proc Clin Dial Transplant Forum (1979) 0.76
Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients. Kidney Int (1996) 0.76
Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions. Transplant Proc (1987) 0.76